These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 17562795)

  • 1. SmaI typeability and tetracycline susceptibility and resistance in Streptococcus pyogenes isolates with efflux-mediated erythromycin resistance.
    Bacciaglia A; Brenciani A; Varaldo PE; Giovanetti E
    Antimicrob Agents Chemother; 2007 Aug; 51(8):3042-3. PubMed ID: 17562795
    [No Abstract]   [Full Text] [Related]  

  • 2. Distribution and molecular analysis of mef(A)-containing elements in tetracycline-susceptible and -resistant Streptococcus pyogenes clinical isolates with efflux-mediated erythromycin resistance.
    Brenciani A; Ojo KK; Monachetti A; Menzo S; Roberts MC; Varaldo PE; Giovanetti E
    J Antimicrob Chemother; 2004 Dec; 54(6):991-8. PubMed ID: 15563518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophage association of mef(A) elements encoding efflux-mediated erythromycin resistance in Streptococcus pyogenes.
    Giovanetti E; Brenciani A; Vecchi M; Manzin A; Varaldo PE
    J Antimicrob Chemother; 2005 Apr; 55(4):445-51. PubMed ID: 15772148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterisation of the main clones of Streptococcus pyogenes carrying the ermA (subclass TR) gene in Spain.
    Montes M; Orden B; Tamayo E; Alos JI; Pérez-Trallero E
    Int J Antimicrob Agents; 2006 Nov; 28(5):408-12. PubMed ID: 17000084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of mef(A)-containing genetic elements in erythromycin-resistant isolates of Streptococcus pyogenes from Italy.
    D'Ercole S; Petrelli D; Prenna M; Zampaloni C; Catania MR; Ripa S; Vitali LA
    Clin Microbiol Infect; 2005 Nov; 11(11):927-30. PubMed ID: 16216111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of emm types 1 and 12 from invasive Streptococcus pyogenes disease in Greece--results of enhanced surveillance.
    Stathi A; Papaparaskevas J; Zachariadou L; Pangalis A; Legakis NJ; Tseleni-Kotsovili A; ; Tassios PT
    Clin Microbiol Infect; 2008 Aug; 14(8):808-12. PubMed ID: 18727807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Tn916-related elements causing erm(B)-mediated erythromycin resistance in tetracycline-susceptible pneumococci.
    Cochetti I; Tili E; Vecchi M; Manzin A; Mingoia M; Varaldo PE; Montanari MP
    J Antimicrob Chemother; 2007 Jul; 60(1):127-31. PubMed ID: 17483548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicentre surveillance of the prevalence and molecular epidemiology of macrolide resistance among pharyngeal isolates of group A streptococci in the USA.
    Green MD; Beall B; Marcon MJ; Allen CH; Bradley JS; Dashefsky B; Gilsdorf JR; Schutze GE; Smith C; Walter EB; Martin JM; Edwards KM; Barbadora KA; Wald ER
    J Antimicrob Chemother; 2006 Jun; 57(6):1240-3. PubMed ID: 16556634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial susceptibility survey of Streptococcus pyogenes isolated in Japan from patients with severe invasive group A streptococcal infections.
    Ikebe T; Hirasawa K; Suzuki R; Isobe J; Tanaka D; Katsukawa C; Kawahara R; Tomita M; Ogata K; Endoh M; Okuno R; Watanabe H
    Antimicrob Agents Chemother; 2005 Feb; 49(2):788-90. PubMed ID: 15673769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SmaI macrorestriction analysis of Italian isolates of erythromycin-resistant Streptococcus pyogenes and correlations with macrolide-resistance phenotypes.
    Ripa S; Zampaloni C; Vitali LA; Giovanetti E; Montanari MP; Prenna M; Varaldo PE
    Microb Drug Resist; 2001; 7(1):65-71. PubMed ID: 11310805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms of high level tetracycline-resistance in group A streptococcal isolates, T serotypes 4 and 11.
    Matsumoto M; Sakae K; Ohta M; Endo M; Okuno R; Murayama S; Hirasawa K; Suzuki R; Isobe J; Tanaka D; Katsukawa C; Tamaru A; Tomita M; Ogata K; Yasuoka T; Ikebe T; Watanabe H;
    Int J Antimicrob Agents; 2005 Feb; 25(2):142-7. PubMed ID: 15664484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence of a novel macrolide-resistant Streptococcus pyogenes emm53 strain.
    Strakova L; Motlova J; Jakubu V; Urbaskova P; Kriz P
    Clin Microbiol Infect; 2007 Apr; 13(4):443-5. PubMed ID: 17359332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrolide, lincosamide and tetracycline susceptibility and emm characterisation of invasive Streptococcus pyogenes isolates in Israel.
    Nir-Paz R; Block C; Shasha D; Korenman Z; Gorodnitzky Z; Jaffe J; Ron M; Michael-Gayego A; Cohen-Poradosu R; Shapiro M; Moses AE
    Int J Antimicrob Agents; 2006 Oct; 28(4):313-9. PubMed ID: 16973336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular epidemiology of group A streptococcus causing scarlet fever in northern Taiwan, 2001-2002.
    Chen YY; Huang CT; Yao SM; Chang YC; Shen PW; Chou CY; Li SY
    Diagn Microbiol Infect Dis; 2007 Jul; 58(3):289-95. PubMed ID: 17532590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonal differences among erythromycin-resistant Streptococcus pyogenes in Spain.
    Perez-Trallero E; Marimón JM; Montes M; Orden B; de Pablos M
    Emerg Infect Dis; 1999; 5(2):235-40. PubMed ID: 10221875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decrease of erythromycin resistance in group A streptococci by change of emm distribution.
    Koh EH; Kim S; Lee NY
    Jpn J Infect Dis; 2008 Jul; 61(4):261-3. PubMed ID: 18653965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin.
    Malhotra-Kumar S; Van Heirstraeten L; Lammens C; Chapelle S; Goossens H
    J Antimicrob Chemother; 2009 May; 63(5):886-94. PubMed ID: 19279051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance to bacitracin in Streptococcus pyogenes from oropharyngeal colonization and noninvasive infections in Portugal was caused by two clones of distinct virulence genotypes.
    Pires R; Rolo D; Mato R; Feio de Almeida J; Johansson C; Henriques-Normark B; Morais A; Brito-Avô A; Gonçalo-Marques J; Santos-Sanches I
    FEMS Microbiol Lett; 2009 Jun; 296(2):235-40. PubMed ID: 19486163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of tet(M), tet(O) and tet(S) in tetracycline/minocycline-resistant Streptococcus pyogenes bacteraemia isolates.
    Hammerum AM; Nielsen HU; Agersø Y; Ekelund K; Frimodt-Moller N
    J Antimicrob Chemother; 2004 Jan; 53(1):118-9. PubMed ID: 14657081
    [No Abstract]   [Full Text] [Related]  

  • 20. Loss of erythromycin resistance genes from strains of Streptococcus pyogenes that have developed resistance to levofloxacin.
    Billal DS; Hotomi M; Yan SS; Fedorko DP; Shimada J; Fujihara K; Yamanaka N
    Diagn Microbiol Infect Dis; 2009 Jun; 64(2):225-8. PubMed ID: 19345038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.